Chrysos Corporation Limited (ASX:C79) Reports Strong Q2 FY25 Results
Chrysos Corporation (ASX:C79) reports strong growth in Q2 FY25, with 12% revenue growth and robust international expansion.
Chrysos Corporation (ASX:C79) reports strong growth in Q2 FY25, with 12% revenue growth and robust international expansion.
Anax Metals (ASX: ANX) has applied for a new exploration license, expanding its footprint in the Pilbara region.
Spectur Limited (ASX:SP3) reports a net cash increase for the quarter, with significant operational revenue growth despite ongoing expenditures.
LTR Pharma Limited (ASX:LTP) partners with Symbion for nationwide distribution of SPONTANĀ®, enhancing access and operational capabilities.
Prospect Resources (ASX:PSC) reports significant copper findings at Nyungu Central, paving the way for extensive future exploration.
Emyria Limited (ASX:EMD) announces leadership changes to bolster its growth in mental health treatments.
Bubs Australia Limited (ASX: BUB) reports significant revenue growth and positive EBITDA for Q2 FY25, highlighting strategic progress and market expansion.
Woodside Energy Group Ltd (ASX:WDS) reports record annual production, highlights project advancements, and outlines future growth plans.
Invex Therapeutics Limited (ASX:IXC) reported significant advancements in Exenatide research and a solid financial position in its December quarterly activities update.
Compumedics Limited (ASX:CMP) announces a new five-year contract with Philips Australia, enhancing its leading Somfit sleep testing program.